retatrutide clinical trials efficacy (RETA) is one of the most promising investigational peptides in obesity research— Retatrutide approval: FDA status, clinical

President Trump announced a new deal this week with drugmakers Eli Lilly and Novo Nordisk, aimed at expanding coverage and lowering prices for GLP-1 medications

The Lactobacillus delbrueckii Surge : Fecal metagenomic sequencing unmasked that Lactobacillus delbrueckii was the single most significantly increased microbial species following liraglutide treatment

Anyone with a history of pancreatitis or gallbladder issues should discuss these risks carefully with their healthcare provider

Gastrointestinal adverse events, including diarrhoea, nausea, and vomiting, were consistently the most common side effects reported across all dose groups in the phase 2 trial

Crewe C, An YA, Scherer PE